145 related articles for article (PubMed ID: 23926900)
21. Protein structure controls the processing of the N-linked oligosaccharides and glycosylphosphatidylinositol glycans of variant surface glycoproteins expressed in bloodstream form Trypanosoma brucei.
Zitzmann N; Mehlert A; Carrouée S; Rudd PM; Ferguson MA
Glycobiology; 2000 Mar; 10(3):243-9. PubMed ID: 10704523
[TBL] [Abstract][Full Text] [Related]
22. In vitro translation in a cell-free system from Trypanosoma brucei yields glycosylated and glycosylphosphatidylinositol-anchored proteins.
Duszenko M; Kang X; Böhme U; Hömke R; Lehner M
Eur J Biochem; 1999 Dec; 266(3):789-97. PubMed ID: 10583372
[TBL] [Abstract][Full Text] [Related]
23. Antigenic variation during the developmental cycle of Trypanosoma brucei.
Hajduk SL
J Protozool; 1984 Feb; 31(1):41-7. PubMed ID: 6204043
[TBL] [Abstract][Full Text] [Related]
24. Deletion of the glucosidase II gene in Trypanosoma brucei reveals novel N-glycosylation mechanisms in the biosynthesis of variant surface glycoprotein.
Jones DC; Mehlert A; Güther ML; Ferguson MA
J Biol Chem; 2005 Oct; 280(43):35929-42. PubMed ID: 16120601
[TBL] [Abstract][Full Text] [Related]
25. Deletion of the TbALG3 gene demonstrates site-specific N-glycosylation and N-glycan processing in Trypanosoma brucei.
Manthri S; Güther ML; Izquierdo L; Acosta-Serrano A; Ferguson MA
Glycobiology; 2008 May; 18(5):367-83. PubMed ID: 18263655
[TBL] [Abstract][Full Text] [Related]
26. Designing sleeping sickness control.
Kinoshita T
ACS Chem Biol; 2008 Oct; 3(10):601-3. PubMed ID: 18928247
[TBL] [Abstract][Full Text] [Related]
27. Depletion of 14-3-3 proteins in bloodstream-form Trypanosoma brucei inhibits variant surface glycoprotein recycling.
Benz C; Engstler M; Hillmer S; Clayton C
Int J Parasitol; 2010 Apr; 40(5):629-34. PubMed ID: 19925803
[TBL] [Abstract][Full Text] [Related]
28. Regulation of antigen gene expression in Trypanosoma brucei.
Pays E
Trends Parasitol; 2005 Nov; 21(11):517-20. PubMed ID: 16126458
[TBL] [Abstract][Full Text] [Related]
29. Autophagic-related cell death of Trypanosoma brucei induced by bacteriocin AS-48.
Martínez-García M; Bart JM; Campos-Salinas J; Valdivia E; Martínez-Bueno M; González-Rey E; Navarro M; Maqueda M; Cebrián R; Pérez-Victoria JM
Int J Parasitol Drugs Drug Resist; 2018 Aug; 8(2):203-212. PubMed ID: 29649664
[TBL] [Abstract][Full Text] [Related]
30. Evidence for a non-LDL-mediated entry route for the trypanocidal drug suramin in Trypanosoma brucei.
Pal A; Hall BS; Field MC
Mol Biochem Parasitol; 2002 Jul; 122(2):217-21. PubMed ID: 12106876
[No Abstract] [Full Text] [Related]
31. Genetics of resistance to the African trypanosomes. VII. Trypanosome virulence is not linked to variable surface glycoprotein expression.
Inverso JA; De Gee AL; Mansfield JM
J Immunol; 1988 Jan; 140(1):289-93. PubMed ID: 3335780
[TBL] [Abstract][Full Text] [Related]
32. The transferrin receptor of Trypanosoma brucei.
Steverding D
Parasitol Int; 2000 Jan; 48(3):191-8. PubMed ID: 11227758
[TBL] [Abstract][Full Text] [Related]
33. Independent regulation of B cell responses to surface and subsurface epitopes of African trypanosome variable surface glycoproteins.
Reinitz DM; Mansfield JM
J Immunol; 1988 Jul; 141(2):620-6. PubMed ID: 2454998
[TBL] [Abstract][Full Text] [Related]
34. In silico identification of novel protective VSG antigens expressed by Trypanosoma brucei and an effort for designing a highly immunogenic DNA vaccine using IL-12 as adjuvant.
Akhoon BA; Slathia PS; Sharma P; Gupta SK; Verma V
Microb Pathog; 2011; 51(1-2):77-87. PubMed ID: 21349321
[TBL] [Abstract][Full Text] [Related]
35. Developmental regulation and extracellular release of a VSG expression-site-associated gene product from Trypanosoma brucei bloodstream forms.
Barnwell EM; van Deursen FJ; Jeacock L; Smith KA; Maizels RM; Acosta-Serrano A; Matthews K
J Cell Sci; 2010 Oct; 123(Pt 19):3401-11. PubMed ID: 20826456
[TBL] [Abstract][Full Text] [Related]
36. 3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasis.
Ferrins L; Rahmani R; Sykes ML; Jones AJ; Avery VM; Teston E; Almohaywi B; Yin J; Smith J; Hyland C; White KL; Ryan E; Campbell M; Charman SA; Kaiser M; Baell JB
Eur J Med Chem; 2013 Aug; 66():450-65. PubMed ID: 23831695
[TBL] [Abstract][Full Text] [Related]
37. VSG mRNA levels are regulated by the production of functional VSG protein.
Maudlin IE; Kelly S; Schwede A; Carrington M
Mol Biochem Parasitol; 2021 Jan; 241():111348. PubMed ID: 33352254
[TBL] [Abstract][Full Text] [Related]
38. Parasite-based screening and proteome profiling reveal orlistat, an FDA-approved drug, as a potential anti Trypanosoma brucei agent.
Yang PY; Wang M; Liu K; Ngai MH; Sheriff O; Lear MJ; Sze SK; He CY; Yao SQ
Chemistry; 2012 Jul; 18(27):8403-13. PubMed ID: 22674877
[TBL] [Abstract][Full Text] [Related]
39. Genetics of resistance to the African trypanosomes. VI. Heredity of resistance and variable surface glycoprotein-specific immune responses.
De Gee AL; Levine RF; Mansfield JM
J Immunol; 1988 Jan; 140(1):283-8. PubMed ID: 3121739
[TBL] [Abstract][Full Text] [Related]
40.
Moreno CJG; Temporão A; Torres T; Sousa Silva M
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30934540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
